Krensavage Asset Management, LLC Long-Term Concentrated

Name: Krensavage Asset Management, LLC Q2 2026 13F Filing | 13F Explorer
Creator: Krensavage Asset Management, LLC
Published: 2026-08-14

Location: New York, NY

CIK: 0001609251 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 14, 2026

Total Value: $263M

Holdings (18)

Increased Positions (4)

ABT ABBOTT LABORATORIES 6.9%

Value $18.15M (+3437.6%) Shares 200,000 (+3900.0%) Est. Cost — Unrealized —

EMBC EMBECTA CORP 1.4%

Value $3.701M (-43.1%) Shares 1,135,340 (+54.4%) Est. Cost — Unrealized —

REGN REGENERON PHARMACEUTICALS 1.4%

Value $3.741M (+21.0%) Shares 6,000 (+50.0%) Est. Cost — Unrealized —

ARDX ARDELYX INC 1.0%

Value $2.726M (-9.0%) Shares 534,523 (+6.9%) Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ABT	ABBOTT LABORATORIES	200,000 (+3900.0%)	$18.15M (+3437.6%)	6.9%	—	—	—	002824100
EMBC	EMBECTA CORP	1,135,340 (+54.4%)	$3.701M (-43.1%)	1.4%	—	—	—	29082K105
REGN	REGENERON PHARMACEUTICALS	6,000 (+50.0%)	$3.741M (+21.0%)	1.4%	—	—	—	75886F107
ARDX	ARDELYX INC	534,523 (+6.9%)	$2.726M (-9.0%)	1.0%	—	—	—	039697107

Exited Positions (2)

INDV INDIVIOR PHARMACEUTICALS INC 3.9%

Value $10.35M Shares 339,532 Est. Cost — Unrealized —

ALKS ALKERMES PLC 1.4%

Value $3.813M Shares 107,822 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
INDV	INDIVIOR PHARMACEUTICALS INC	339,532	$10.35M	3.9%	—	—	—	45579U109
ALKS	ALKERMES PLC	107,822	$3.813M	1.4%	—	—	—	G01767105

Decreased Positions (2)

UTHR UNITED THERAPEUTICS CORP 14.3%

Value $37.54M (-24.9%) Shares 69,282 (-17.8%) Est. Cost — Unrealized —

EXEL EXELIXIS INC 7.7%

Value $20.17M (+13.1%) Shares 370,693 (-10.8%) Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
UTHR	UNITED THERAPEUTICS CORP	69,282 (-17.8%)	$37.54M (-24.9%)	14.3%	—	—	—	91307C102
EXEL	EXELIXIS INC	370,693 (-10.8%)	$20.17M (+13.1%)	7.7%	—	—	—	30161Q104

Unchanged Positions (12)

JAZZ JAZZ PHARMACEUTICALS PLC 15.4%

Value $40.44M Shares 167,816 Est. Cost — Unrealized —

ENTA ENANTA PHARMACEUTICALS INC 15.9%

Value $41.79M Shares 2,866,138 Est. Cost — Unrealized —

RARE ULTRAGENYX PHARMACEUTICAL IN 5.0%

Value $13.05M Shares 390,879 Est. Cost — Unrealized —

SNY SANOFI-ADR 5.3%

Value $13.82M Shares 323,946 Est. Cost — Unrealized —

SUPN SUPERNUS PHARMACEUTICALS INC 5.0%

Value $13.05M Shares 280,681 Est. Cost — Unrealized —

VNDA VANDA PHARMACEUTICALS INC 2.7%

Value $7.224M Shares 1,180,388 Est. Cost — Unrealized —

BIIB BIOGEN INC 1.6%

Value $4.321M Shares 20,000 Est. Cost — Unrealized —

EOLS EVOLUS INC 0.4%

Value $1.096M Shares 157,985 Est. Cost — Unrealized —

BMRN BIOMARIN PHARMACEUTICAL INC 11.4%

Value $30.03M Shares 524,786 Est. Cost — Unrealized —

GSK GSK PLC-SPON ADR 1.9%

Value $5.071M Shares 96,729 Est. Cost — Unrealized —

BNTX BIONTECH SE-ADR 2.1%

Value $5.539M Shares 59,523 Est. Cost — Unrealized —

INMD INMODE LTD 0.7%

Value $1.768M Shares 120,942 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
JAZZ	JAZZ PHARMACEUTICALS PLC	167,816	$40.44M	15.4%	—	—	—	G50871105
ENTA	ENANTA PHARMACEUTICALS INC	2,866,138	$41.79M	15.9%	—	—	—	29251M106
RARE	ULTRAGENYX PHARMACEUTICAL IN	390,879	$13.05M	5.0%	—	—	—	90400D108
SNY	SANOFI-ADR	323,946	$13.82M	5.3%	—	—	—	80105N105
SUPN	SUPERNUS PHARMACEUTICALS INC	280,681	$13.05M	5.0%	—	—	—	868459108
VNDA	VANDA PHARMACEUTICALS INC	1,180,388	$7.224M	2.7%	—	—	—	921659108
BIIB	BIOGEN INC	20,000	$4.321M	1.6%	—	—	—	09062X103
EOLS	EVOLUS INC	157,985	$1.096M	0.4%	—	—	—	30052C107
BMRN	BIOMARIN PHARMACEUTICAL INC	524,786	$30.03M	11.4%	—	—	—	09061G101
GSK	GSK PLC-SPON ADR	96,729	$5.071M	1.9%	—	—	—	37733W204
BNTX	BIONTECH SE-ADR	59,523	$5.539M	2.1%	—	—	—	09075V102
INMD	INMODE LTD	120,942	$1.768M	0.7%	—	—	—	M5425M103